CBAT Pilot Studies are attracting attention because they test whether carbon-based advanced treatment can support water reuse without relying on reverse osmosis as the default advanced-treatment barrier. The evidence available from recent pilots is encouraging in some respects, but it also shows that implementation depends on feedwater chemistry, byproduct control, adsorbent life, cost exposure, and public acceptance. These studies should be read as field-tested demonstrations, not proof that one treatment train will work under all wastewater conditions.

What The 2026 Midwest Pilots Showed

Water Quality Gains And Remaining Gaps

A 2026 study of two Midwest carbon-based advanced treatment pilots, one at a small facility of about 10 MGD and one at a larger facility above 100 MGD, reported treated-water quality below 0.5 mg/L total Kjeldahl nitrogen and below 2 mg/L total organic carbon. The same study reported substantial reductions in emerging contaminants, which supports the view that ozone, biofiltration, and carbon adsorption can address several organic contaminant concerns in reuse applications. Those findings came from real wastewater treatment contexts rather than bench-only screening, which makes them relevant for utilities considering demonstration-scale work.

The same results also show why scale-up decisions need caution. The Midwest pilots did not remove nitrate and total dissolved solids to meet drinking water standards. That limitation matters because carbon-based treatment is not expected to behave like a desalting membrane. Where nitrate, salinity, or dissolved inorganic constituents are controlling compliance questions, a CBAT train may need upstream controls, blending, additional treatment, or a different treatment objective. The published Midwest paper is therefore best read as evidence of selective strengths and specific gaps, not as a universal potable-reuse design template. The reported findings are described in the peer-reviewed Midwest CBAT pilots.

Byproducts From Ozone Treatment

Ozone is often central to carbon-based advanced treatment because it can oxidize organic contaminants and improve downstream biological filtration. The same oxidation step can also create regulated or health-relevant byproducts. In the Midwest pilots, bromate formation during ozonation exceeded 10 µg/L, the U.S. EPA drinking water maximum contaminant level cited in the research notes, with reported averages around 30 µg/L and peaks up to 65 µg/L. Some nitrosamines, including NDMA, increased after ozone and required downstream biofiltration to fall below comparison levels such as California’s notification level or public health goal cited in the study summary.

This is not a reason to dismiss ozone-biofiltration. It is a reason to treat byproduct formation as a design constraint rather than a late-stage commissioning issue. Bromide levels, amine precursors, pH, ozone dose, peroxide use, contact conditions, and blending practices can affect the outcome. The research notes identify these as mitigation pathways, but they are not interchangeable fixes. A pilot that succeeds under one seasonal chemistry profile may perform differently during wet weather, industrial discharge shifts, or combined sewer events.

Why CBAT Pilot Studies Are Hard To Scale

CBAT Pilot Studies And Source-Water Variability

Implementation risk often begins before advanced treatment. Secondary effluent is not a fixed feedstock. It changes with storm events, industrial inputs, nutrient-removal performance, organic loading, temperature, and upstream plant operation. In the Midwest work, periods with higher bromide and variable secondary effluent conditions were associated with elevated bromate formation. That finding supports a practical requirement: pilots need to sample across credible operating ranges, not only during stable weather or favorable plant performance.

CBAT Pilot Studies therefore need operating envelopes that define what has been demonstrated. A utility should be able to say which feedwater conditions were observed, which critical limits were challenged, and which conditions remain outside the evidence base. Without that boundary, a pilot can give decision-makers false confidence. For application teams, the relevant question is not whether the average data look acceptable; it is whether the treatment train remains controllable during the credible high-risk periods identified for that source water.

Adsorbent Exhaustion And Cost Exposure

Activated carbon and related adsorbents are valuable because they can remove a range of organic contaminants, including some contaminants of emerging concern. Their performance is not permanent. Research notes from recent pilots describe increasing finished-water concentrations of some PFAS and other organic contaminants as granular activated carbon became exhausted. Other pilot evidence from Southern California found that high total organic carbon, around 6 mg/L, and elevated PFAS levels above 1,000 ng/L shortened substrate life for PFAS adsorption from treated wastewater intended for aquifer recharge. Pretreatment that reduced TOC reportedly extended adsorbent life by about threefold in that case.

That type of result changes the cost discussion. Capital equipment may be visible in early estimates, but media changeout, disposal or regeneration, monitoring frequency, labor, and downtime can drive lifecycle cost. A pilot-scale hybrid process using membrane filtration with activated carbon adsorption reportedly achieved high pharmaceutical removal during the first 24 hours, but the effectiveness dropped after that early period. The reported cost estimate depended on onsite solvent recovery for regeneration. Those details suggest that cost claims should identify assumptions about regeneration, waste handling, contaminant loading, and operating duration.

Acceptance, Regulation, And Demonstration Design

What Acceptance Evidence Supports

Water reuse implementation is not only a treatment question. Public and regulatory acceptance can affect whether a technically promising option moves beyond pilot stage. A 2026 qualitative comparative analysis found that successful potable water reuse implementation was associated with factors such as early public education, visible pilot or demonstration facilities, and clear governance conditions; some cases included education beginning 24 months before decision-making and demonstration centers that made treatment processes observable to stakeholders. The evidence is comparative and case-based, so it should not be treated as a formula, but it does indicate that acceptance work cannot be postponed until design is nearly complete. The implementation findings are summarized in a peer-reviewed water reuse acceptance analysis.

For technical teams, this means a demonstration plan should document both performance and decision transparency. Sampling plans, byproduct findings, uncertainty ranges, and non-detections need to be communicated in terms that regulators, boards, and community reviewers can evaluate. A pilot that produces high-quality water but does not explain monitoring limits may still fail as a decision-support tool. The same caution applies to adjacent wastewater process-change reporting; a related evidence-limits discussion appears in this chlorine-free wastewater analysis.

Evidence Boundaries For Application Teams

Application teams should separate three questions: what the pilot achieved, what it did not address, and what would change at full scale. The first question is answered by measured treated-water quality, removal performance, and byproduct monitoring. The second includes nitrate, TDS, bromate, NDMA, PFAS breakthrough, wet-weather feedwater shifts, and any contaminant groups not included in the sampling program. The third includes media replacement logistics, residuals handling, operator training, regulatory reporting, and the cost of maintaining performance over long operating periods.

• Define source-water ranges before judging pilot success.
• Track bromide, precursor chemistry, ozone dose, and downstream biofiltration performance together.
• Measure adsorbent breakthrough over enough bed volumes to support changeout planning.
• Report nitrate and TDS separately from organic-contaminant removal.
• Connect public communication to actual pilot data rather than generic reuse claims.

For those exploring similar topics, Lili Live Steam offers related content within the same network, though it focuses on broader discussions distinct from the specifics of water-reuse outcomes featured here.

CBAT Pilot Studies Require Evidence Gates

The most defensible use of carbon-based advanced treatment pilots is as a staged evidence gate. A pilot can show whether ozone, biofiltration, activated carbon, and related processes can meet target removal goals for a defined water source. It can also reveal where the treatment train is weak: bromate under high bromide conditions, nitrosamine control after ozone, nitrate and TDS persistence, and adsorbent exhaustion under high organic loading.

For CBAT Pilot Studies, the practical decision should not be framed as “works” or “does not work.” A better decision record states the feedwater conditions tested, the treatment objectives achieved, the objectives not achieved, the byproducts observed, the monitoring limits, and the operational assumptions behind cost. That record gives utilities and regulators a clearer basis for deciding whether CBAT is suitable as a stand-alone approach, part of a hybrid train, or a non-potable reuse option with different treatment targets.